1. Homepage
  2. Equities
  3. Singapore
  4. Singapore Stock Exchange
  5. TalkMed Group Limited
  6. Summary
    5G3   SG2G61000003

TALKMED GROUP LIMITED

(5G3)
  Report
Delayed Singapore Stock Exchange  -  09:07 2022-06-30 pm EDT
0.3850 SGD    0.00%
05/23ANNUAL REPORTS AND RELATED DOCUMENTS : :
PU
04/08TALKMED : Cancellation of Virtual Information Session
PU
04/05TALKMED : Annual Report 2021
PU
 SummaryQuotesChartsNewsRatingsCalendarCompanyFinancials 
Quotes 5-day view   Delayed Quote. Delayed Singapore Stock Exchange
06/14/2022 06/16/2022 06/20/2022 06/21/2022 06/30/2022 Date
0.385(c) 0.385(c) 0.39(c) 0.39(c) 0.385(c) Last
200 3 200 100 0 5 000 Volume
0.00% 0.00% +1.30% 0.00% -1.28% Change
More quotes
Estimated financial data (e)
Sales 2020 62,3 M 44,8 M 44,8 M
Net income 2020 22,8 M 16,4 M 16,4 M
Net cash position 2020 69,3 M 49,8 M 49,8 M
P/E ratio 2020 26,2x
Yield 2020 3,00%
Sales 2021 60,9 M 43,8 M 43,8 M
Net income 2021 25,1 M 18,1 M 18,1 M
Net cash position 2021 73,1 M 52,6 M 52,6 M
P/E ratio 2021 20,6x
Yield 2021 4,10%
Capitalization 509 M 366 M 366 M
EV / Sales 2020 8,41x
EV / Sales 2021 7,25x
Nbr of Employees -
Free-Float 14,2%
More Financials
Company
TalkMed Group Limited is a Singapore-based investment holding company. The Company’s Oncology services segment is engaged in the provision of oncology services to Parkway Cancer Centre, a division of Parkway Hospitals Singapore Pte. Ltd., Thu Cuc International General Hospital in Hanoi, Vietnam and Hong Kong Integrated Oncology Centre Holdings Limited. The Company has expanded its oncology services to China. Its... 
More about the company
All news about TALKMED GROUP LIMITED
05/23ANNUAL REPORTS AND RELATED DOCUMENTS : :
PU
04/08TALKMED : Cancellation of Virtual Information Session
PU
04/05TALKMED : Annual Report 2021
PU
03/30TALKMED : Circular 2022
PU
03/15TalkMed Group Issues Shares Upon Vesting of Share Awards
MT
02/16TalkMed Logs Higher Profit, Revenue in H2 2021
MT
02/15TalkMed Group Limited Reports Earnings Results for the Full Year Ended December 31, 202..
CI
02/15TalkMed Group Limited Proposes Final Dividend, Payable on 11 May 2022
CI
2021TALKMED : Unit Extends Agreement to Provide Medical Oncology Services to Parkway Hospitals..
MT
2021TALKMED : Awards 2.5 Million Shares Under Performance Share Plan
MT
2021GENERAL ANNOUNCEMENT : :business update on the group's latest business development
PU
2021EMPLOYEE STOCK OPTION/ SHARE SCHEME : :grant of share awards pursuant to the talkmed group..
PU
2021DISCLOSURE OF INTEREST/ CHANGES IN I : :Notification of Interests in Securities by Directo..
PU
2021GENERAL ANNOUNCEMENT : :changes to the composition of the board and board committee
PU
2021Talkmed Group Limited Announces Changes to the Composition of the Board and Board Commi..
CI
More news
News in other languages on TALKMED GROUP LIMITED
02/16TalkMed enregistre une hausse de son bénéfice et de son chiffre d'affaires au second se..
02/15TalkMed Group Limited présente ses résultats pour l'exercice complet terminé le 31 déce..
02/15TalkMed Group Limited propose un dividende final, payable le 11 mai 2022
2021Une unité du groupe TalkMed crée une coentreprise pour aider les hôpitaux partenaires e..
2021Le bénéfice attribuable de TalkMed a augmenté de 1 % au premier semestre.
More news
Chart TALKMED GROUP LIMITED
Duration : Period :
TalkMed Group Limited Technical Analysis Chart | MarketScreener
Full-screen chart
Income Statement Evolution
Managers and Directors
Peng Tiam Ang Chief Executive Officer & Executive Director
Boon Yong Lee Chief Financial Officer & Joint Secretary
Sitaram Chandra Das Independent Non-Executive Chairman
Kei Siong Khoo Chief Operating Officer & Executive Director
Yih Pin Sitoh Independent Non-Executive Director
Sector and Competitors